Penicillin and Streptomycin Market Revenue Drivers, Growth Opportunities, Supply Chain Analysis and Forecast Research Report till 2022
“Global Penicillin and Streptomycin Market is expected to grow at a significant CAGR in the upcoming period as the scope and its applications are rising enormously across the globe.”
Global Penicillin and Streptomycin Market research report offers a complete breakdown of the industry scope, assumptions, segmentation, key strategies, revenue, shares and size of top players. This syndicated research report also provides application, regional, products insights and offer ready, data-driven answers to many industry-level questions. Market Overview: Global Penicillin and Streptomycin Market is expected to grow at a significant CAGR in the upcoming period as the scope and its applications are rising enormously across the globe. Penicillin and streptomycin are the antibiotics that are used to avert bacterial contamination of cell cultures due to their active mutual action against gram-negative and gram-positive bacteria. Penicillin is derived from the fungi “Penicillium” and streptomycin from “Streptomyces griseus”. Penicillin-streptomycin solution is exclusively used as a supplement in several types of media like α-MEM (minimum essential medium) growth medium, Dulbecco’s modified eagle′s medium, and RGC (retinal ganglion cells) culture. Key Players: • Takeda Pharmaceutical • Abbot Laboratories • Eli Lilly and Co • Bristol Myers Squibb